ObsEva SA (OBSV) said Monday that it has appointed David Renas as Chief Financial Officer and member of the company's Executive Committee, effective today. He will be based in the U.S.
Renas has more than 30 years of financial and legal experience, including 15 years within the pharmaceutical and life sciences industry. Most recently, he served as CFO at Petra Pharma and CFO and General Counsel at Sangart.
He also served as a Partner at Adkins Black LLP. He was an attorney in private practice with Gray Cary Ware & Freidenrich and Foley & Lardner, and a CPA at Deloitte.
For comments and feedback contact: editorial@rttnews.com
Business News
April 17, 2026 15:29 ET The ongoing conflict in the Middle East continues to raise concerns for policymakers who worry about the impact of the supply shock and high energy prices on the real economy. Producer price data and various survey results on the housing market were the main news from the U.S. this week. In Europe, industrial production data for the euro area gained attention. GDP figures out of China and the policy move by the Singapore central bank were in focus in Asia.